Advancing site readiness for CAR-T delivery in autoimmune indications | Case studies with practical insights. Over recent years, there has been rapid growth in the clinical development pipeline for CAR T therapies in autoimmune indications. These trials introduce new and complex challenges for the sector, including the need for shared care delivery pathways and coordinated clinical infrastructure. To ensure the…
12.30 - 2.00pm Hosted by Elaine Ferguson Talks by Emma Bain Developing humanised cell models to test therapies for osteoarthritis David Coe Getting T-cell therapies to their target: The importance of chemokines and their receptors in designing T-cell therapies
This education day has been organised to focus on CAR T clinical trials within the field of autoimmune conditions. It aims to bring together a range of expert speakers from across Scotland and the UK, each with significant expertise in advanced therapy clinical trials. This event is hosted by the Advanced Therapy Treatment Centre (ATTC) network and the Scottish Steering…
Agenda and venue tbc
NHS colleagues from across Wales, local companies and the wider industry sector will join to share clinical innovation in practice to improve patient outcomes. The event includes presentations, workshops and networking. Keynote speakers for 2026: Jacqueline Totterdell, Chief Executive for NHS Wales and Director General for Health, Social Care and Early Years Isabel Oliver, Chief Medical Officer for Wales The…
Agenda & venue tbc
Perfusion intensification, cold harvest stabilization, and inline affinity capture together can more than double lentiviral vector (LVV) recovery while removing steps from the process. This session presents a continuous LVV workflow that reached around 12 × 10⁶ viable cells/mL before transfection and delivered roughly 16-fold higher cumulative transduction units over 3 days through cold harvest handling. Keen Chung, Technical Lead…
Advanced Therapies Europe is a focused conference and networking event for the advanced therapies and regenerative medicine community. It brings together key people across European biotech and life sciences to discuss innovation, investment and bringing new treatments to market. Sessions explore a wide range of issues across the advanced therapies field, including clinical development, commercial strategy, regulatory planning, manufacturing, market…
This webinar explores the scientific and analytical capabilities required to support precision medicine programs across advanced modalities such as cell and gene therapy, and complex therapeutic areas, including oncology and neurology. Join an expert panel as they explore key considerations in potency assessment, safety monitoring and evidence generation, with a focus on building integrated strategies that support development from early…
Join us for the Cardiff Cancer Research Partners (CCRP) Annual Conference 2026, bringing together researchers, clinicians, students and partners from across the cancer research community for a day of knowledge sharing, collaboration and networking. The conference will showcase the breadth of cancer research taking place across Cardiff and Wales, with presentations covering clinical research, discovery science, translational research, drug development, precision…
Serum is one of the largest sources of variability in T cell manufacturing, driving lot-to-lot inconsistency, sourcing constraints, and contamination risk. This data-led session shows you how a chemically defined, serum-free workflow removes that dependency, so you can build more reproducible processes from early development through clinical scale. Chengkang Zhang will walk through experimental data on the impact of serum…
Join us at the 4th Annual Advanced Therapies Wales Symposium, the only annual event in Wales dedicated to Advanced Therapies, taking place on Thursday 17 September, 09:00–17:30, at the stunning Great Hall, Swansea University Bay Campus. Set against a vibrant waterfront backdrop, this flagship gathering brings together researchers, clinicians, industry partners, and policymakers to explore the full pathway from bench…